Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Pulmonary Hypertension

  Free Subscription


1 Am J Case Rep
3 Am J Manag Care
1 Am J Physiol Heart Circ Physiol
2 Am J Physiol Lung Cell Mol Physiol
2 Am J Respir Crit Care Med
1 Angiol Sosud Khir
1 Basic Res Cardiol
1 Biomolecules
1 BMC Cardiovasc Disord
1 BMJ Case Rep
1 Br J Clin Pharmacol
1 Br J Radiol
7 Cardiovasc Diagn Ther
4 Chest
1 Cureus
1 Eur Heart J
1 Exp Cell Res
1 Front Endocrinol (Lausanne)
2 Front Physiol
1 Hematology
1 Hepatology
1 Int J Ophthalmol
1 J Biomech Eng
2 J Card Fail
1 J Coll Physicians Surg Pak
1 J Perinatol
1 J Physiol
1 PLoS One
2 Pulm Circ
2 Pulm Pharmacol Ther
1 Resuscitation
1 Rev Mal Respir
1 Rev Port Cardiol (Engl Ed)
2 Sci Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Case Rep

  1. KAULINS R, Vitola B, Lejniece S, Lejnieks A, et al
    Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report.
    Am J Case Rep. 2021;22:e933031.
    PubMed         Abstract available

    Am J Manag Care

    Reducing economic burden and improving quality of life in pulmonary arterial hypertension.
    Am J Manag Care. 2021;27.
    PubMed         Abstract available

  3. GALE S
    The evolving treatment landscape of pulmonary arterial hypertension.
    Am J Manag Care. 2021;27.
    PubMed         Abstract available

    Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients.
    Am J Manag Care. 2021;27.
    PubMed         Abstract available

    Am J Physiol Heart Circ Physiol

  5. LANG IM, Thurner S
    Computer modeling to predict balloon pulmonary angioplasty success.
    Am J Physiol Heart Circ Physiol. 2021;321:H567-H568.

    Am J Physiol Lung Cell Mol Physiol

  6. DE MAN FS, Vonk-Noordegraaf A
    The magic of communication: the need to study organ and cell communication in pulmonary arterial hypertension-induced right heart failure.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L634-L636.

  7. NAKAHARA M, Ito H, Skinner JT, Lin Q, et al
    The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L416-L428.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  8. ZAMANIAN RT, Badesch D, Chung L, Domsic RT, et al
    Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
    Am J Respir Crit Care Med. 2021;204:209-221.
    PubMed         Abstract available

  9. WANG G, Wen B, Ren X, Li E, et al
    Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras.
    Am J Respir Crit Care Med. 2021;204:326-338.
    PubMed         Abstract available

    Angiol Sosud Khir

  10. EVLAKHOV VI, Poiasov IZ, Ovsiannikov VI
    [Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects].
    Angiol Sosud Khir. 2021;27:16-21.
    PubMed         Abstract available

    Basic Res Cardiol

  11. BAI Y, Wang J, Chen Y, Lv T, et al
    The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-beta-signalling pathways in an SMC/EC-crosstalk-associated manner.
    Basic Res Cardiol. 2021;116:53.
    PubMed         Abstract available


  12. CALLEJO M, Morales-Cano D, Mondejar-Parreno G, Barreira B, et al
    Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K(+) Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency.
    Biomolecules. 2021;11.
    PubMed         Abstract available

    BMC Cardiovasc Disord

  13. FREDERIKSEN CA, Waziri F, Ringgaard S, Mellemkjaer S, et al
    Reverse remodeling of tricuspid valve morphology and function in chronic thromboembolic pulmonary hypertension patients following pulmonary thromboendarterectomy: a cardiac magnetic resonance imaging and invasive hemodynamic study.
    BMC Cardiovasc Disord. 2021;21:450.
    PubMed         Abstract available

    BMJ Case Rep

  14. ASMAT H, Fayeye F, Alshakaty H, Patel J, et al
    A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital.
    BMJ Case Rep. 2021;14.
    PubMed         Abstract available

    Br J Clin Pharmacol

  15. KLINGER JR, Chakinala MM, Langleben D, Rosenkranz S, et al
    Riociguat: Clinical research and evolving role in therapy.
    Br J Clin Pharmacol. 2021;87:2645-2662.
    PubMed         Abstract available

    Br J Radiol

  16. HARDACRE CJ, Robertshaw JA, Barratt SL, Adams HL, et al
    Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review.
    Br J Radiol. 2021 Sep 19:20210332. doi: 10.1259/bjr.20210332.
    PubMed         Abstract available

    Cardiovasc Diagn Ther

  17. LAMMERS AE, Apitz C, Michel-Behnke I, Koestenberger M, et al
    A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension.
    Cardiovasc Diagn Ther. 2021;11:1160-1177.
    PubMed         Abstract available

  18. LAMMERS AE, Apitz C
    Update from the World Symposium on Pulmonary Hypertension 2018: does the new hemodynamic definition of pediatric pulmonary hypertension have an impact on treatment strategies?
    Cardiovasc Diagn Ther. 2021;11:1048-1051.
    PubMed         Abstract available

  19. KRAMER J, Beer M, Kaestner M, Bride P, et al
    Moyamoya disease associated with pediatric pulmonary hypertension-a case report.
    Cardiovasc Diagn Ther. 2021;11:1052-1056.
    PubMed         Abstract available

  20. LATUS H, Meierhofer C
    Role of cardiovascular magnetic resonance in pediatric pulmonary hypertension-novel concepts and imaging biomarkers.
    Cardiovasc Diagn Ther. 2021;11:1057-1069.
    PubMed         Abstract available

  21. KAESTNER M, Apitz C, Lammers AE
    Cardiac catheterization in pediatric pulmonary hypertension: a systematic and practical approach.
    Cardiovasc Diagn Ther. 2021;11:1102-1110.
    PubMed         Abstract available

  22. HERBERG U, Knies R, Muller N, Breuer J, et al
    Altitude exposure in pediatric pulmonary hypertension-are we ready for (flight) recommendations?
    Cardiovasc Diagn Ther. 2021;11:1122-1136.
    PubMed         Abstract available

  23. APITZ C, Lammers AE
    Pediatric pulmonary hypertension.
    Cardiovasc Diagn Ther. 2021;11:1023-1027.


  24. TATAH JH, Weir EK, Prins KW, Thenappan T, et al
    A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.
    Chest. 2021;159:e193-e196.
    PubMed         Abstract available

  25. OPPEGARD LJ, Hedstrom G, Levene J, Desai S, et al
    A 44-Year-Old Man Presenting With Massive Hemoptysis and Dyspnea.
    Chest. 2021;159:e237-e241.
    PubMed         Abstract available

  26. GALLINI JW, Benkeser D, Cui X, Shah AJ, et al
    Pulmonary hypertension: a new vascular complication of diabetes?
    Chest. 2021 Sep 16. pii: S0012-3692(21)03863-0. doi: 10.1016/j.chest.2021.

  27. CERTAIN MC, Chaumais MC, Jais X, Savale L, et al
    Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Chest. 2021;159:1197-1207.
    PubMed         Abstract available


  28. BUYSSE J, Billa RD, McLennan D, Ashwath R, et al
    Infantile Scimitar Syndrome With Contralateral Pulmonary Vein Stenosis and Refractory Pulmonary Hypertension.
    Cureus. 2021;13:e17203.
    PubMed         Abstract available

    Eur Heart J

    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.

    Exp Cell Res

  30. CERECEDO D, Martinez-Vieyra I, Lopez-Villegas EO, Hernandez-Cruz A, et al
    Heterogeneity of neutrophils in arterial hypertension.
    Exp Cell Res. 2021;402:112577.
    PubMed         Abstract available

    Front Endocrinol (Lausanne)

  31. GONCALVES AESS, Rocha GZ, Marin R, Camargo RL, et al
    Pulmonary Hypertension in Obese Mice Is Accompanied by a Reduction in PPAR-gamma Expression in Pulmonary Artery.
    Front Endocrinol (Lausanne). 2021;12:701994.
    PubMed         Abstract available

    Front Physiol

  32. LUO L, Chen Q, Yang L, Zhang Z, et al
    MSCs Therapy Reverse the Gut Microbiota in Hypoxia-Induced Pulmonary Hypertension Mice.
    Front Physiol. 2021;12:712139.
    PubMed         Abstract available

  33. APPLEGATE TJ, Krafsur GM, Boon JA, Zhang H, et al
    Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension.
    Front Physiol. 2021;12:712583.
    PubMed         Abstract available


  34. DURU A, Madu AJ, Okoye H, Nonyelu C, et al
    Variations and characteristics of the various clinical phenotypes in a cohort of Nigerian sickle cell patients.
    Hematology. 2021;26:684-690.
    PubMed         Abstract available


  35. RAEVENS S, Boret M, De Pauw M, Fallon MB, et al
    Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
    Hepatology. 2021;74:1674-1686.
    PubMed         Abstract available

    Int J Ophthalmol

  36. ZHANG HJ, Huang R, Liang L, Zhou F, et al
    Vision loss as the initial presentation during primary pulmonary hypertension treatment.
    Int J Ophthalmol. 2021;14:1460-1462.

    J Biomech Eng

  37. XU J, Desmond EL, Wong TC, Neill CG, et al
    Right Ventricular Shape Feature Quantification for Evaluation of Pulmonary Hypertension: Feasibility and Preliminary Associations with Clinical Outcome Submitted for Publication.
    J Biomech Eng. 2021 Sep 22. pii: 1120496. doi: 10.1115/1.4052495.
    PubMed         Abstract available

    J Card Fail

  38. NAJJAR E, Lund LH, Hage C, Nagy AI, et al
    The differential impact of the Left Atrial pressure components on Pulmonary Arterial Compliance-Resistance relationship in Heart Failure.
    J Card Fail. 2020 Sep 18. pii: S1071-9164(20)30955.
    PubMed         Abstract available

  39. KITTIPIBUL V, Blumer V, Angsubhakorn N, Hernandez GA, et al
    Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
    J Card Fail. 2021;27:477-485.
    PubMed         Abstract available

    J Coll Physicians Surg Pak

  40. SIDDIQUE M, Nawaz MK, Khalid MB, Rai A, et al
    Right to Left Intrapulmonary Shunt in a Case with COVID-19-associated Pneumonia.
    J Coll Physicians Surg Pak. 2021;31:S23-S25.
    PubMed         Abstract available

    J Perinatol

  41. LOPATA SM, Slaughter JC, Gillam-Krakauer M, Reese J, et al
    The patent ductus arteriosus management debate: it's not over yet.
    J Perinatol. 2021;41:923-925.

    J Physiol

    Pulmonary hypertension associated with chronic hypoxia: just ASIC-ness?
    J Physiol. 2021 Sep 17. doi: 10.1113/JP282325.


  43. WALTER K
    Pulmonary Hypertension.
    JAMA. 2021;326:1116.

    PLoS One

  44. WAKABAYASHI SI, Joshita S, Kimura K, Motoki H, et al
    Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
    PLoS One. 2021;16:e0249435.
    PubMed         Abstract available

    Pulm Circ

  45. LI Y, Li Y, Li L, Yin M, et al
    PKR deficiency alleviates pulmonary hypertension via inducing inflammasome adaptor ASC inactivation.
    Pulm Circ. 2021;11:20458940211046156.
    PubMed         Abstract available

  46. XIONG M, Jain PP, Chen J, Babicheva A, et al
    Mouse model of experimental pulmonary hypertension: Lung angiogram and right heart catheterization.
    Pulm Circ. 2021;11:20458940211041512.
    PubMed         Abstract available

    Pulm Pharmacol Ther

  47. RAHAGHI FF, Allen RP, Balasubramanian VP, Chakinala MM, et al
    An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil.
    Pulm Pharmacol Ther. 2021;66:101979.
    PubMed         Abstract available

  48. ENGLERT L, Stadlbauer C, Spaeth M, Hofmann HS, et al
    Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model.
    Pulm Pharmacol Ther. 2021;66:101985.
    PubMed         Abstract available


  49. MORGAN RW, Himebauch AS, Griffis H, Quarshie WO, et al
    Pulmonary hypertension among children with in-hospital cardiac arrest: a multicenter study.
    Resuscitation. 2021 Sep 15. pii: S0300-9572(21)00363.
    PubMed         Abstract available

    Rev Mal Respir

  50. MONTANI D, Girerd B, Humbert M
    [Screening for pulmonary veno-occlusive disease: A specific approach].
    Rev Mal Respir. 2021;38:215-216.

    Rev Port Cardiol (Engl Ed)

  51. PINTO FF
    Percutaneous closure of patent ductus arteriosus: A standard procedure with new perspectives.
    Rev Port Cardiol (Engl Ed). 2021;40:569-571.

    Sci Rep

  52. OH S, Jang AY, Chae S, Choi S, et al
    Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Sci Rep. 2021;11:2012.
    PubMed         Abstract available

  53. TURA-CEIDE O, Smolders VFED, Aventin N, Moren C, et al
    Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2021;11:18797.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.